Wang 2000.

Methods	Design: randomised, placebo‐ controlled, double‐blind parallel groups, 3 months
Participants	Country: Taiwan n=50 prob AD NINCDS/ADRDA, (47completers) mild‐ moderate dementia (MMSE: 10‐26). Aged 72 (SD 9). Natural menopause ? (all had pap smears). Exclusion criteria: diabetes, cancer, hypertension, active disease, depression, use cognition enhancers last 3 months, use HRT last month.
Interventions	1. CEE oral 1.25 mg/day 2. Placebo
Outcomes	General: (MMSE‐CE, CASI)
Notes	no effect HRT over placebo 0/2 tests. Adverse events: 11 had vaginal bleeding